7.2 Evidence-Based Practice, Clinical Audit & Quality Improvement

Key Takeaways

  • Evidence-Based Practice (EBP) integrates the best available research evidence with clinical nursing expertise, patient values, and cultural context.
  • The hierarchy of research evidence places Systematic Reviews and Meta-Analyses of RCTs at Level I (highest validity), descending to expert opinion at Level V.
  • The Plan-Do-Study-Act (PDSA) cycle is the foundational methodology for small-scale, iterative quality improvement tests of change in clinical environments.
  • Clinical auditing systematically evaluates nursing practice against explicit, evidence-based standards to identify practice gaps and drive measurable improvement.
  • The Health Quality & Safety Commission (HQSC) Aotearoa NZ drives national safety initiatives, including Fall Prevention, Surgical Safety Checklists, and Pressure Injury Reduction.
Last updated: July 2026

Evidence-Based Practice, Clinical Audit & Quality Improvement

Quality improvement and evidence-based practice are central tenets of professional nursing in Aotearoa New Zealand. Registered Nurses are required under Nursing Council of New Zealand (NCNZ) Competency Domain 4 to contribute to continuous quality improvement, critically evaluate research findings, and apply evidence to enhance patient safety and healthcare equity.


1. Evidence-Based Practice (EBP) in Nursing

Evidence-Based Practice (EBP) is defined as the conscientious, explicit, and judicious use of current best evidence in making decisions about the care of individual patients. EBP synthesizes three foundational components:

                  ┌───────────────────────────────────────────┐
                  │       Best Available Research Evidence    │
                  └─────────────────────┬─────────────────────┘
                                        │
                                        ▼
    ┌─────────────────────────┐   ┌───────────────────────────┐
    │ Clinical Expertise &    ├══►│  Evidence-Based Nursing   │
    │ Professional Judgment   │   │     Clinical Decision     │
    └─────────────────────────┘   └─────────────┬─────────────┘
                                                │
                                                ▼
                  ┌───────────────────────────────────────────┐
                  │ Consumer Values, Cultural Preferences &   │
                  │           Whānau Priorities               │
                  └───────────────────────────────────────────┘

The PICO/PICOT Framework for Clinical Inquiry

To search for high-quality evidence efficiently, nurses structure clinical questions using the PICO (or PICOT) format:

  • P (Population / Patient / Problem): Specific patient demographic or clinical condition (e.g., adult surgical patients with indwelling urinary catheters).
  • I (Intervention): The proposed clinical intervention or practice (e.g., nurse-led catheter removal protocol).
  • C (Comparison): Standard care or alternative intervention (e.g., physician-ordered catheter removal).
  • O (Outcome): Desired measurable outcome (e.g., reduction in catheter-associated urinary tract infections [CAUTIs] and hospital length of stay).
  • T (Timeframe): Duration of evaluation (e.g., within 30 days post-operatively).

2. Hierarchy of Evidence

Not all clinical evidence carries equal scientific weight. When reviewing literature to update clinical guidelines or nursing procedures, RNs categorize evidence according to established evidence hierarchies:

LevelStudy Design & Evidence TypeClinical Reliability & Application
Level ISystematic Reviews & Meta-Analyses of Randomized Controlled Trials (RCTs); Clinical Practice Guidelines based on systematic reviews.Highest Quality: Minimal bias; gold standard for evaluating treatment efficacy and guiding national guidelines.
Level IIWell-designed individual Randomized Controlled Trials (RCTs).High quality; strong internal validity for cause-and-effect relationships.
Level IIIWell-designed controlled trials without randomization (quasi-experimental studies), cohort studies, or case-control studies.Moderate quality; useful when RCTs are ethically or practically unfeasible.
Level IVNon-experimental descriptive studies, qualitative research, mixed-methods studies, and case series.Provides deep contextual insight, patient experiences, and qualitative understanding (e.g., culturally safe care experiences).
Level VOpinions of expert committees, clinical consensus statements, expert opinion reports, and traditional narrative reviews.Lowest hierarchy level; valuable for emerging clinical topics where empirical data is sparse, but subject to expert bias.

3. The Clinical Audit Cycle

A clinical audit is a quality improvement process that seeks to improve patient care and outcomes through systematic review of care against explicit, evidence-based criteria and the implementation of change.

The 5 Stages of the Audit Cycle

  1. Stage 1 — Select Topic & Define Standards: Identify a clinical issue (e.g., surgical site infection rates) and select explicit, evidence-based standards (e.g., pre-operative antiseptic skin preparation guidelines).
  2. Stage 2 — Data Collection: Audit patient records or observe practices to collect baseline data over a defined timeframe.
  3. Stage 3 — Compare Performance Against Standards: Analyze audit data to determine compliance percentages and identify practice gaps.
  4. Stage 4 — Implement Change: Develop and execute targeted interventions (e.g., staff education, new skin prep kits, checklist integration) to address root causes of non-compliance.
  5. Stage 5 — Re-Audit (Closing the Loop): Repeat data collection after a set period to measure the impact of interventions and confirm sustained improvement.

4. The Plan-Do-Study-Act (PDSA) Quality Improvement Model

The Plan-Do-Study-Act (PDSA) cycle, developed by Deming and popularized by the Institute for Healthcare Improvement (IHI), is widely utilized across New Zealand District Health networks for rapid-test quality improvement initiatives.

                  ┌──────────────────────────────────────────┐
                  │                1. PLAN                   │
                  │  • Define objective & change hypothesis  │
                  │  • Plan data collection & task allocation│
                  └────────────────────┬─────────────────────┘
                                       │
                                       ▼
  ┌─────────────────────────┐                    ┌─────────────────────────┐
  │         4. ACT          │                    │          2. DO          │
  │ • Adapt, Adopt or Abandon│                    │ • Execute test on small │
  │ • Prepare next cycle or │                    │   scale                 │
  │   scale up change       │                    │ • Document problems &   │
  └─────────────────────────┘                    │   unexpected data       │
               ▲                                 └────────────┬────────────┘
               │                                              │
               │                  3. STUDY                    │
               └──────────────────────────────────────────────┘
                 • Analyze data against baseline predictions
                 • Summarize key learnings & unexpected outcomes

Phases of the PDSA Cycle

  • Plan: State the objective, formulate a clear prediction/hypothesis, identify data collection metrics, and plan who will do what, when, and where.
  • Do: Carry out the test on a small, manageable scale (e.g., testing a new fall risk assessment tool on a 5-bed sub-unit for 3 days). Document unexpected problems and collect observation data.
  • Study: Complete data analysis, compare results against initial predictions, evaluate process metrics, and summarize key insights learned.
  • Act: Based on findings, determine the next step: Adopt (implement the change hospital-wide), Adapt (modify the intervention and run a refined PDSA cycle), or Abandon (discard the change if evidence shows no benefit or harm).

5. Health Quality & Safety Commission (HQSC) Aotearoa Initiatives

The Health Quality & Safety Commission (HQSC) leads national quality and safety programs across New Zealand. Key national safety priority areas include:

  • National Patient Safety Markers (PSMs): Benchmarked indicators tracking clinical compliance in areas such as:
    • Fall Prevention: Individualized fall risk assessments and care plans (e.g., "Safe Practice, Effective Care").
    • Pressure Injury Prevention: Routine skin risk scoring (Waterlow/Braden scales) and pressure-relieving surface deployment.
    • Hand Hygiene New Zealand (HHNZ): Observational auditing of the WHO 5 Moments for Hand Hygiene.
    • Surgical Safety Checklist: Pre-incision "Time Out" verification in operating theatres.
    • Central Line-Associated Bacteraemia (CLAB) Prevention: Insertion and maintenance aseptic bundles in ICU settings.
  • Adverse Event Reporting & Root Cause Analysis (RCA): Systems like RiskMan or Datix facilitate transparent event reporting. Serious Adverse Events (SAC 1 and SAC 2 ratings) undergo structured Root Cause Analysis (RCA) to uncover systemic vulnerabilities rather than assigning individual fault, driving a just culture focused on organizational learning.
Loading diagram...
Integration of Clinical Audit Cycle & PDSA Continuous Improvement Loop
Test Your Knowledge

A clinical nurse specialist conducts a systematic review and meta-analysis of randomized controlled trials regarding non-pharmacological interventions for post-operative pain management. According to the standard hierarchy of research evidence, which level does this study represent?

A
B
C
D
Test Your Knowledge

A ward quality improvement team introduces a new bedside shift handover template. They test the template with just two nurses during a single night shift, collect immediate feedback, and observe documentation completeness. Which phase of the PDSA cycle does this small-scale execution represent?

A
B
C
D
Test Your Knowledge

What is the primary operational distinction between a research study and a clinical audit in healthcare settings?

A
B
C
D
Test Your Knowledge

A hospital ward experiences an unexpected Medication Sentinel Event (SAC 1 incident). Following national Health Quality & Safety Commission (HQSC) guidelines, how should the clinical leadership respond to this event?

A
B
C
D